Characterization of Epidermal Growth Factor Receptor ( EGFR ) P848L, an Unusual EGFR Variant Present in Lung Cancer Patients, in a Murine Ba/F3 Model

FEBS Open Bio - United States
doi 10.1002/2211-5463.12702
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer

HPB
HepatologyGastroenterology
2016English

BRAF; Epidermal Growth Factor Receptor (EGFR)

Science-Business eXchange
2012English

Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

AXL/epidermal Growth Factor Receptor (EGFR) Complexes in Breast Cancer - Culprits for Resistance to EGFR Inhibitors?

Breast Cancer Research
Cancer ResearchOncology
2013English

Epidermal Growth Factor Receptor (EGFR): A Rising Star in the Era of Precision Medicine of Lung Cancer

Oncotarget
Oncology
2017English

The Association Between Epidermal Growth Factor Receptor (EGFR) Gene Polymorphisms and Lung Cancer Risk

Biomolecules
BiochemistryMolecular Biology
2018English

UBPY-mediated Epidermal Growth Factor Receptor (EGFR) De-Ubiquitination Promotes EGFR Degradation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Cranial Irradiation for Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy